☆ 4.5 Article

Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primates

VACCINE (2023)

Related references

Note: Only part of the references are listed.

Review Medicine, General & Internal

Intranasal COVID-19 vaccines: From bench to bed

Aqu Alu et al.

Summary: Currently licensed COVID-19 vaccines are administered intramuscularly and fail to activate mucosal immunity, which contributes to the inability to prevent upper respiratory tract infection. The demand for the next generation of COVID-19 vaccines that can induce both mucosal and systemic immune responses has led to the investigation of intranasal vaccination. Several intranasal vaccines against SARS-CoV-2 are currently under intensive investigation, with 12 candidates in clinical trials at different phases.

EBIOMEDICINE (2022)

Add to Collection

Review Pharmacology & Pharmacy

Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics

P. Vervaeke et al.

Summary: The success of mRNA-based COVID-19 vaccines signals a new chapter in modern medicine, but the regulatory framework for mRNA therapeutics lags behind. This review discusses guidelines for preclinical biodistribution studies of mRNA/siRNA therapeutics and highlights the differences for mRNA vaccines. The study also explores the role of in vivo RNA imaging techniques and other assays in meeting regulatory requirements.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Add to Collection

Editorial Material Immunology

Operation Nasal Vaccine-Lightning speed to counter COVID-19

Eric J. Topol et al.

SCIENCE IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination

Jinyi Tang et al.

Summary: SARS-CoV-2 mRNA vaccination induces strong immune responses in the circulation, but its effectiveness in the respiratory tract, especially against variants of concern like Omicron, is still uncertain. This study found lower neutralizing antibody responses in the respiratory tract of vaccinated individuals compared to COVID-19 convalescents, despite robust antibody responses in the blood. Vaccination also induced circulating B and T cell immunity, but these responses were absent in the respiratory tract. Mouse immunization experiments showed that systemic mRNA vaccination alone resulted in weak respiratory mucosal neutralizing antibody responses, but combining it with mucosal adenovirus-S immunization produced strong neutralizing antibody responses against both the ancestral virus and the Omicron variant. Overall, this study suggests that current COVID-19 vaccines are highly effective against severe disease, but provide limited protection against breakthrough infections, particularly by the Omicron sublineage.

SCIENCE IMMUNOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Characterization and Specification of a Trivalent Protein-Based Pneumococcal Vaccine Formulation Using an Adjuvant-Free Nanogel Nasal Delivery System

Yoshikazu Yuki et al.

Summary: The study developed a nasal vaccine delivery system using nanogel and successfully encapsulated three PspA antigens. Results showed efficient release of PspA with heat treatment affecting immunologic activity.

MOLECULAR PHARMACEUTICS (2021)

Add to Collection

Article Immunology

A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci

Rika Nakahashi-Ouchida et al.

Summary: A polysaccharide-based pneumococcal vaccine has been developed to effectively inhibit various serotypes of Streptococcus pneumoniae infections, demonstrating good immunogenicity and protective efficacy in macaques. The vaccine induces PspA-specific IgGs, triggers complement C3 deposition, and enhances resistance to pneumococcal infections by inhibiting lung inflammation and reducing bacterial numbers in the lungs.

VACCINE (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Namit Chaudhary et al.

Summary: mRNA vaccines have been established as a rapid, effective, and safe approach for protecting individuals from infectious diseases, especially during the COVID-19 pandemic. Further research is needed to optimize mRNA vaccine design, delivery, and applications for a range of infectious diseases.

NATURE REVIEWS DRUG DISCOVERY (2021)

Add to Collection

Article Cell Biology

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models

Neeltje van Doremalen et al.

Summary: Intranasal vaccination with ChAdOx1 nCoV-19/AZD1222 reduced viral loads in nasal swabs in vaccinated macaques and hamsters challenged with SARS-CoV-2, indicating potential for further investigation as a vaccination route for COVID-19 vaccines.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Review Immunology

Mucosal vaccines: wisdom from now and then

Hiroshi Kiyono et al.

Summary: The mucosal immune system in the oral and nasal cavities plays a crucial role in recognizing pathogens and initiating immune responses. Dental science has been a key driving force in studying mucosal immunity and developing mucosal vaccines for oral infectious diseases. Mucosal immunology and vaccines have now become significant entities in the discipline of immunology.

INTERNATIONAL IMMUNOLOGY (2021)

Add to Collection

Article Immunology

The first 12 months of COVID-19: a timeline of immunological insights

Thiago Carvalho et al.

Summary: The timeline of major scientific discoveries during the first year of the COVID-19 pandemic highlights the collaborative efforts that led to rapid progress in understanding the immune response to SARS-CoV-2. It showcases the unprecedented convergence of research efforts on COVID-19 and identifies gaps in knowledge for future investigations.

NATURE REVIEWS IMMUNOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for Pancreatic Cancer

Sadaf Aghevlian et al.

MOLECULAR PHARMACEUTICS (2018)

Add to Collection

Article Immunology

Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques

Y. Fukuyama et al.

MUCOSAL IMMUNOLOGY (2015)

Add to Collection

Article Immunology

Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniae

Il Gyu Kong et al.

INFECTION AND IMMUNITY (2013)

Add to Collection

Article Immunology

In Vivo Molecular Imaging Analysis of a Nasal Vaccine That Induces Protective Immunity against Botulism in Nonhuman Primates

Yoshikazu Yuki et al.

JOURNAL OF IMMUNOLOGY (2010)

Add to Collection

Article Biochemical Research Methods

A facile automated synthesis of N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB) for 18F-labeled cell-penetrating peptide as PET tracer

Ganghua Tang et al.

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2010)

Add to Collection

Article Chemistry, Physical

Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines

Tomonori Nochi et al.

NATURE MATERIALS (2010)

Add to Collection

Review Immunology

Mucosal vaccines: novel advances in technology and delivery

Yoshikazu Yuki et al.

EXPERT REVIEW OF VACCINES (2009)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Skeletal PET with F-18-fluoride: Applying new technology to an old tracer

Frederick D. Grant et al.

JOURNAL OF NUCLEAR MEDICINE (2008)

Add to Collection

Review Biochemistry & Molecular Biology

Mucosal immunity and vaccines

J Holmgren et al.

NATURE MEDICINE (2005)

Add to Collection

Article Medicine, General & Internal

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

M Mutsch et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Add to Collection

Article Chemistry, Multidisciplinary

Nasal drug delivery - possibilities, problems and solutions

L Illum

JOURNAL OF CONTROLLED RELEASE (2003)

Add to Collection

Article Chemistry, Multidisciplinary

Hierarchical self-assembly of hydrophobically modified pullulan in water: Gelation by networks of nanoparticles

K Kuroda et al.

LANGMUIR (2002)

Add to Collection

Article Immunology

Cutting edge: The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

FW van Ginkel et al.

JOURNAL OF IMMUNOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.